Esperion Therapeutics Inc (ESPR)
2.08
+0.02
(+0.97%)
USD |
NASDAQ |
May 03, 16:00
2.08
0.00 (0.00%)
After-Hours: 20:00
Esperion Therapeutics Total Return Level: 2.08 for May 3, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 03, 2024 | 2.08 |
May 02, 2024 | 2.06 |
May 01, 2024 | 2.04 |
April 30, 2024 | 1.97 |
April 29, 2024 | 1.99 |
April 26, 2024 | 1.90 |
April 25, 2024 | 1.99 |
April 24, 2024 | 2.13 |
April 23, 2024 | 2.09 |
April 22, 2024 | 1.91 |
April 19, 2024 | 1.95 |
April 18, 2024 | 1.87 |
April 17, 2024 | 1.84 |
April 16, 2024 | 1.91 |
April 15, 2024 | 1.935 |
April 12, 2024 | 2.14 |
April 11, 2024 | 2.31 |
April 10, 2024 | 2.52 |
April 09, 2024 | 2.79 |
April 08, 2024 | 3.03 |
April 05, 2024 | 3.24 |
April 04, 2024 | 3.11 |
April 03, 2024 | 3.12 |
April 02, 2024 | 2.88 |
April 01, 2024 | 2.79 |
Date | Value |
---|---|
March 28, 2024 | 2.68 |
March 27, 2024 | 2.62 |
March 26, 2024 | 2.70 |
March 25, 2024 | 2.62 |
March 22, 2024 | 2.29 |
March 21, 2024 | 2.11 |
March 20, 2024 | 2.19 |
March 19, 2024 | 2.08 |
March 18, 2024 | 2.05 |
March 15, 2024 | 2.07 |
March 14, 2024 | 2.05 |
March 13, 2024 | 2.19 |
March 12, 2024 | 2.05 |
March 11, 2024 | 2.12 |
March 08, 2024 | 2.19 |
March 07, 2024 | 2.28 |
March 06, 2024 | 2.46 |
March 05, 2024 | 2.40 |
March 04, 2024 | 2.44 |
March 01, 2024 | 2.55 |
February 29, 2024 | 2.51 |
February 28, 2024 | 2.57 |
February 27, 2024 | 2.90 |
February 26, 2024 | 2.63 |
February 23, 2024 | 2.61 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.7304
Minimum
Oct 26 2023
73.84
Maximum
Feb 13 2020
19.67
Average
9.26
Median
Nov 11 2021
Total Return Level Benchmarks
United Therapeutics Corp | 262.40 |
Dynavax Technologies Corp | 11.74 |
Heron Therapeutics Inc | 2.61 |
Aldeyra Therapeutics Inc | 4.16 |
Deciphera Pharmaceuticals Inc | 25.38 |